Authorization

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-shortened week.

Shares of companies with a COVID portfolio, including a vaccine, a treatment or both, reacted with strong moves to the upside in the truncated session on Friday.

Takeda Pharmaceutical Company Limited (NYSE:TAK) and Aadi Bioscience, Inc. (NASDAQ:AADI) received Food and Drug Administration nod for their Livtencity and Fyarro, respectively.

Here are the catalysts that could impact trading in the upcoming week:



Conferences





The Evercore ISI 4th Annual HealthCONx Virtual Conference: Nov. 30-Dec. 2

Piper Sandler 33rd Annual Virtual Healthcare Conference: Nov. 29-Dec. 2

American Epilepsy Society, or AES, 2021 Annual Meeting: Dec. 3-7, in Illinois, Chicago
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2022    »
ПнВтСрЧтПтСбВс
 12
3456789
10111213141516
17181920212223
24252627282930
31